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ABSTRACT
Background: Approximately 16.2% of the Japanese population suffer from cedar pollinosis , with various
manifestations such as ophthalmic, laryngo-pharyngeal and skin symptoms in addition to nasal symptoms.
Thus, the annual pollen season is an agonizing period for patients. No study has reported symptoms and their
clinical courses after conjunctival provocation with purified cedar pollen allergen Cry j1 as well as suppression
of these allergen-induced ocular symptoms by antihistamine eye drops.
Methods: Nine patients with Japanese cedar pollinosis who had no nasal or ocular symptoms were included
in the present study, after obtaining informed consent in writing. 1) Purified cedar pollen allergen Cry j1 was in-
stilled in the left eye and phosphate-buffered saline (PBS) in the right eye as a control. 2) Levocabastine hydro-
chloride ophthalmic suspension and ketotifen fumarate ophthalmic solution were respectively instilled in the left
and right eyes, which were then challenged with the allergen. Ocular symptoms after provocation with the aller-
gen were recorded through the clinical course.
Results: Pollen allergen-induced ocular symptoms were itching and hyperemia of the palpebral conjunctiva,
and itching lasted for more than 5 hours. Moreover, preadministration of antihistamine eye drops suppressed
the increases in the ocular symptom scores, eliminating itching within 1 hour. Allergen provoked not only ocular
symptoms but also nasal symptoms in 77.8% of patients.
Conclusions: Preadministration of antihistamine eye drops suppressed the symptoms induced by the aller-
gen, which suggests that this is an effective early therapy for Japanese cedar pollinosis, if it is started before
the pollen season. However, self-protection by patients using a mask may not be effective enough to suppress
nasal symptoms during the pollen season, requiring them to additionally wear glasses to avoid exposure to the
allergen.
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INTRODUCTION
Approximately 16.2% of the Japanese population suf-
fer from cedar pollinosis, which is one of the most
common seasonal allergic diseases in Japan . 1 Be-
cause various symptoms including ocular , laryngo-
pharyngeal, and skin symptoms are simultaneously
manifested in addition to nasal symptoms, the annual
pollen season is agonizing for patients.2
Anti-allergic or steroid eye drops are major thera-
pies for allergic conjunctivitis. However, steroid eye
drops, with excellent anti-inflammatory action, should
be used with care because of adverse drug reactions
after continuous use, such as glaucoma. Therefore,
anti-allergic eye drops are selected as a first-line ther-
apy for allergic conjunctivitis. Anti-allergic eye drops
are classified into two types according to their action
mechanisms; suppression of the release of chemical
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Fig. 1 Protocol of the conjunctival provocation test
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Fig. 2 Relationship between itching score and cumulative 
dose of Cry j1.
Score 1 Score 2 or higher
C
um
ul
at
iv
e 
do
se
 o
f C
ry
 j1
0.001
0.01
0.1
1
10
100
1000
Itching score
(ng)Table 1 Subjective symptom scores for alergic conjunctivitis.
ScoreSymptoms
0: none (no itching)
Itching
1: mild (mild continuous itching that does not re-
quire rubbing)
2: moderate (itching that requires rubbing)
3: severe (subject cannot resist urge to rub eyes)
0: none (no tear formation)
Tearing
1: mild (slight tear formation)
2: moderate (marked tear formation necessitat-
ing frequent wiping of the eyes)
3: severe (tears roling down cheeks)
mediators and blockage of histamine H1-receptors .
Major symptoms of allergic conjunctivitis such as
itching, hyperemia, and edema are mediated by hista-
mine H1-receptors, and therefore, antihistamine eye
drops are expected to be “fast-acting.” Levocabastine
hydrochloride is a potent and specific antagonist to
histamine H1-receptors.3 In our previous study on the
nasal provocation test with Japanese cedar allergen, a
levocabastine hydrochloride nasal spray was found ef-
fective in suppressing nasal symptoms.4 In addition,
some studies on conjunctival provocation with levo-
cabastine hydrochloride ophthalmic suspension con-
trolled by placebo 5 or sodium cromoglycate eye
drops , 6 reported that levocabastine hydrochloride
rapidly suppressed ocular symptoms.
In the present study, Cry j1, which is the purified
allergen of Japanese cedar pollen, was newly used for
performing the conjunctival provocation test in pa-
tients with Japanese cedar pollinosis during its as-
ymptomatic period, so as to investigate the induced
symptoms and their clinical courses as well as sup-
pression of these allergen-induced ocular symptoms
by antihistamine eye drops.
METHODS
SUBJECTS
Nine adult patients with Japanese cedar pollinosis
who had no nasal or ocular symptoms were included
in the present study from October to November .
They were given an explanation about the study be-
fore participating, and written informed consent was
obtained from all of the patients. All of the patients
had a history of ocular symptoms during the pollen
season, confirmed by means of either a positive skin
prick test or serum Japanese cedar pollen specific
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Fig. 3 Time course of mean itching score in the conjuncti-
val provocation test. Cry j1 (●) and PBS (○) was instiled 
in the left and right eye, respectively (n＝5).
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Fig. 4 Time course of mean itching score in the conjuncti-
val provocation test after antihistamine eye drops were 
administrated. Levocabastine hydrochloride (● ) and keto-
tifen fumarate (○ ) was instiled in the left and right eye, 
respectively (n＝9). There was no significant diference be-
tween the two antihistamine eye drops.
Time past antigen challenge (min)
M
ea
n 
itc
hi
ng
 s
co
re
0.0
0.5
1.0
1.5
0 5 10 15 20 25 30 35 40 45 50 55 60
IgE antibody level (class 2 or higher).
METHODS
Purified cedar pollen allergen Cry j1 was purchased
from Seikagaku Corp. (Tokyo, Japan). The allergen
Cry j1 was diluted with sterile phosphate-buffered sa-
line (PBS) to concentrations of 10 pg, 100 pg, 1 ng, 10
ng, 100 ng, and 1 μg per 50 μl immediately before use
for the conjunctival provocation test . Levocabastine
hydrochloride ophthalmic suspension (Livostin® Eye
Drops 0.025%) was purchased from Nippon Shinyaku
Co., Ltd. (Kyoto, Japan) and ketotifen fumarate oph-
thalmic solution (Zaditen® ophthalmic solution) was
purchased from Novartis Pharma K.K. (Tokyo, Ja-
pan) . This study was a single-masked comparative
study. A clinical evaluation was performed mainly on
the patients’ subjective symptoms with a view of
evaluating the patients’ quality of life (QOL).
THRESHOLD DOSE OF PURIFIED CEDAR POL-
LEN ALLERGEN CRY J1 FOR MANIFESTATION
OF OCULAR SYMPTOMS
Five male patients with Japanese cedar pollinosis
(mean age 40.6 years) were instilled with 40 μl of the
allergen solution in the left eye and 40 μl of sterile
PBS in the right eye. According to the dosing regi-
men shown in Figure 1 , instillation of the allergen
started with a low dose (8 pg), and the affected eye
was observed for 10 minutes after every instillation.
Until ocular symptoms of score 2 or higher were in-
duced, the concentration of allergen was stepwise in-
creased (80 pg, 800 pg, 8 ng, 80 ng, and 800 ng) in
the left eye, while PBS was instilled in the right eye.
The severity of itching and tearing was given a score
of 3 for severe symptoms, 2 for moderate symptoms,
1 for mild symptoms, and 0 for no symptoms (Table
1).
All of the patients were followed up to record symp-
toms for 6 hours after provocation.
COMPARISON OF PREVENTIVE EFFECTS
AGAINST ALLERGEN-INDUCED SYMPTOMS
BETWEEN ANTIHISTAMINE EYE DROPS
Two drops each of levocabastine hydrochloride oph-
thalmic suspension and ketotifen fumarate ophthal-
mic solution were instilled in the left and right eye,
respectively, in patients with Japanese cedar pollino-
sis (7 male and 2 female patients : mean age 39.2
years , including 5 patients for investigating the
threshold dose) . According to the dosing regimen
shown in Figure 1 , the allergen dose was investi-
gated and set at 800 ng for all patients because mod-
erate symptoms scored 2 or higher were observed in
all patients at 800 ng in the threshold dose setting
study. Then, 800 ng of allergen each was instilled in
both eyes 10 minutes after instillation with the re-
spective eye drops , and the eyes were observed
through the clinical course.
STATISTICAL ANALYSIS
The data were statistically analyzed by the Wilcoxon’s
matched-pair signed-rank test method.
RESULTS
THRESHOLD DOSE FOR INDUCING OCULAR
SYMPTOMS
The dose of allergen was increased stepwise, and the
actual exposure to the allergen is represented by the
cumulative dose. Figure 2 shows the cumulative dose
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Table 2 Other subjective symptoms observed in the conjunctival provocation test.
headacheaural itchingnasal congestionnasal mucussneezingNasal itchingCase No.
――○○○○1
―――○―○2
―○―――○3
―――――○4
―――――○5
―――――○6
―――――○7
○―――――8
――――――9
of allergen at which the itching severity was scored
as 1 and 2 or higher. While there were individual dif-
ferences in the provoking dose of allergen, patients
all showed moderate symptoms scored 2 or higher at
the cumulative dose of 800 ng. On the basis of these
dose-finding study results, the dose of Cry j1 allergen
was set at 800 ng in the comparative study of antihis-
tamine eye drops.
CHANGES IN THE ITCHING SCORE OVER TIME
IN THE CONJUNCTIVAL PROVOCATION TEST
Figure 3 shows the time course of the mean itching
score in the conjunctival provocation test. The itching
severity after instillation with PBS was kept and
scored as low as 0.2 without any changes. In contrast,
the mean score in the allergen-induced eye reached
1.0 at 5 minutes, 1.5 at 15 minutes, and a maximum of
2.2 at 25 minutes. At 4 hours the score was reduced
to 1.0, although the itching was retained for a dura-
tion of 6 hours or more. In the present test, tearing
occurred in no patients.
COMPARISON OF PREVENTIVE EFFECTS
AGAINST INDUCTION OF OCULAR SYMPTOMS
BY ALLERGEN BETWEEN THE ANTIHISTAMINE
EYE DROPS
Preadministration with antihistamine eye drops low-
ered the mean highest score of itching to 0.9 at 15
minutes for levocabastine hydrochloride and 1.0 at 20
minutes for ketotifen fumarate , and thereafter , the
symptom disappeared within 60 minutes after the
provocation (Fig. 4). In the conjunctival provocation
test, the symptom score of itching reached a maxi-
mum of 2.2 with the itching persisting for more than
6 hours (Fig. 3). Therefore, the present study indi-
cated that preadministration of antihistamine eye
drops apparently suppressed the onset of the symp-
toms. Although no significant difference in the ocular
symptom-suppressing efficacy was seen between
these antihistamine eye drops, the mean score 0.1 at
30 minutes of levocabastine hydrochloride was lower
than the mean score 0.7 of ketotifen fumarate oph-
thalmic solution. In the present study , no adverse
events were observed, except that one patient com-
plained of irritation at administration with levo-
cabastine hydrochloride ophthalmic suspension and
so did 5 patients with ketotifen fumarate ophthalmic
solution.
Symptoms other than ocular symptoms were ob-
served in the present conjunctival provocation test
(Table 2). Nasal itching was the most frequent, and
occurred in 77.8% of patients . Other symptoms in-
cluded sneezing, nasal discharge, aural itching, and
headache.
DISCUSSION
Our previous questionnaire survey in patients with
Japanese cedar pollinosis who visited otolaryngolo-
gists revealed that nasal symptoms developed in
99.8% of the patients, with ocular symptoms in 90.5%,
laryngopharyngeal symptoms in 52.6% , and skin
symptoms in 24.8%, and that allergic conjunctivitis is
a complication in the majority of patients . 2 This
means that treatment of allergic conjunctivitis may
benefit patients with Japanese cedar pollinosis. Aller-
gic conjunctivitis is nowadays treated by antiallergy
or steroid eye drops in most cases, but continuous
use of steroid eye drops is associated with adverse
drug reactions such as glaucoma, even though they
are excellent in anti-inflammatory action. Therefore,
use of such eye drops is limited only to a short term
under appropriate follow-up of the symptoms. In con-
trast, antiallergy eye drops are widely used as a pri-
mary drug with less adverse drug reactions. Antihis-
tamine eye drops are expected to be fast-acting, be-
cause they block histamine H1-receptors involved in
the main complaints of allergic conjunctivitis such as
itching , hyperemia , and edema . Eye drops of ke-
totifen fumarate and levocabastine hydrochloride
were developed as such products in Japan, and are
now clinically used. Levocabastine hydrochloride, a
long acting, highly potent and selective histamine H1-
receptor antagonist was developed as a topical anti-
histaminic drug for nasal and ophthalmic use. Levo-
cabastine hydrochloride has been demonstrated to
be potent and long-acting antihistaminic activity
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against compound 4880-induced shock in rats, com-
pared with other antihistaminic drugs.3 It has also
been reported that levocabastine hydrochloride is
fast- and long-acting as compared with ketotifen fu-
marate in a rat model of allergic conjunctivitis.7
In our present study on the conjunctival provoca-
tion test with purified cedar pollen allergen Cry j1,
the induced symptoms and their changes were ob-
served over time to investigate suppression of the
allergen-induced symptoms by antihistamine eye
drops. Conjunctival provocation tests were performed
by a method to instill the allergen in the conjunctival
sac to induce antigen-antibody reactions , which is
used for definite diagnosis of allergic conjunctivitis.8,9
In addition, these tests are used to evaluate pharma-
cological efficacy, and have been reported for provo-
cation by cedar pollen allergen.10-15 Various methods
were attempted, whereas we established the method
for conjunctival provocation tests with purified cedar
pollen allergen Cry j1. In this study, the clinical aller-
gic reactions were observed in the same manner as
the conventional method.
The allergen-induced major ocular symptoms were
itching and hyperemia of the palpebral conjunctiva in
comparison between Japanese cedar pollen antigen
and placebo. All of the patients showed the moderate
itching symptom (score 2 or higher) when the aller-
gen dose was accumulated to 800 ng . While the
placebo-instilled eye showed no symptomatic
changes with the mean score being as low as 0.2, the
allergen-induced eye showed ocular symptoms, the
mean score of which was 1.0 at 5 minutes after the
provocation and a maximum of 2.2 at 25 minutes after
the provocation ( Fig . 3 ) . The threshold dose
showed individual differences in the induction of ocu-
lar symptoms , as previously reported in the nasal
provocation test.4 Usually, moderate or severe ocular
symptoms persist for more than 6 hours , and are
likely to affect the patients’ QOL. From this view-
point, suppression of the onset of ocular symptoms is
beneficial for patients . Preadministration of levo-
cabastine hydrochloride or ketotifen fumarate effec-
tively suppressed induction of symptoms by aller-
gens, eliminating the ocular itching symptom within
1 hour . Although there were no significant differ-
ences between the two pretreatment groups , levo-
cabastine hydrochloride ophthalmic suspension ap-
peared to remit the symptoms earlier at 30 minutes
or so. A combination of eye drops and nasal spray of
levocabastine hydrochloride has been reported to ef-
fectively suppress seasonal allergic symptoms due to
white birch pollen, being useful as an early therapy,16
and the present study results suggested that levo-
cabastine hydrochloride is expected to be beneficial
for patients as an early therapy for Japanese cedar
pollinosis. In the present study, neither of antihista-
mine eye drops caused adverse events, but one pa-
tient complained of irritation at administration with
levocabastine hydrochloride ophthalmic suspension
and so did 5 patients at instillation with ketotifen fu-
marate ophthalmic solution. This difference in induc-
tion of irritation was likely to be attributable to the dif-
ference in pH of both eye drops:ketotifen fumarate
ophthalmic solution, acidic with a pH of 4.8 to 5.8;
levocabastine hydrochloride ophthalmic suspension,
almost neutral with a pH of 6.0 to 8.0.
From the above results, we conclude that continu-
ous exposure to a small quantity of pollen allergen
drifting before the day when the cedar pollen disper-
sion starts may elevate the sensitivity to the allergen,
and therefore, use of antihistamine eye drops as an
early therapy before drift of the pollen is an effective
therapy to suppress substantial manifestation of ocu-
lar symptoms. In addition, as the allergen stimulated
the nasal mucosa through the nasolacrimal canal and
induced nasal symptoms in the present conjunctival
provocation test , self-protection from allergic reac-
tions using a mask may not be effective enough dur-
ing the pollen season, requiring patients to addition-
ally wear glasses to avoid exposure to the allergen.
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